The company posted an adjusted profit of $1.14 per share, higher than analysts’ expectations for an adjusted profit of $1.05 per share. Despite the impressive reports, Pfizer lowers its forecasts for 2023 to revenues of $69 billion, when the market expected it to bring in about $73.9 billion next year. In addition, Pfizer anticipates that next year it will register an adjusted profit of $3.35 per share compared to the expectation of an adjusted annual profit of $4.44 per share.
More in-
Pfizer shares fell 15% since the beginning of the year to a price of $43.55 and a market value of $244 billion. In all likelihood, Pfizer will not be able to reproduce the success and its revenues will fall in 2023. As you may recall, Pfizer recently announced that it is raising the prices for the Corona vaccine to approximately 110 to 130 dollars per dose, in order to meet its forecasts for the last year.